Pfizer Antibody Medicinal TIVDAK Won EMA Panel Confirmation (PFE: NYSE)


Concept image of an anticancer drug called ADC. 3D Show

mesh cube

  • The European Medical Agency has a committee for drugs for human use given PFizer's positive opinion (NYSE:PFE) Antibody medicine for metastatic cervical cancer TIVDAK (Tisotumab Vedotin).
  • Pfizer said the treatment was working, “he said.



Source link

اترك تعليقاً

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *

DMCA.com Protection Status